Key result
Among 78 cardiac outpatients, the prevalence of dilated cardiomyopathy was 17.9%, with the most frequently prescribed treatment being a combination of loop and potassium-sparing diuretics.
Why the study?
Cardiomyopathies are heterogeneous myocardial diseases with varied causes, often genetic, and understanding pharmacotherapeutic patterns in dilated cardiomyopathy is needed.
Observational (n=78)
No
This small observational study highlights the demographic profile and standard pharmacological management of dilated cardiomyopathy in a single Indian center.
Background: AHA defines cardiomyopathies as a heterogeneous group of diseases of the myocardium associated with mechanical and/or electrical dysfunction that usually (but not invariably) exhibit inappropriate ventricular hypertrophy or dilatation and are due to a variety of causes that frequently are genetic.Methods: This is a prospective observational study conducted in the year 2017 at an OPD of Cardiology of a private hospital located in Telangana state, India. Data has been collected after diagnosis is made and treatment regimen is given by an Interventional Cardiologist.Results: Data has been collected from 78 cardiac patients, out of which 17.9% patients had Dilated Cardiomyopathy (DCM) among them 57.14% were male. In the present study DCM was reported more in the age group of 61-70 years (42.85%). Treatment pattern in most of the prescriptions include Diuretics, Beta blockers, Angiotensin Converting Enzyme Inhibitors (ACEI), Angiotensin Receptor Blockers (ARBs), Cardiac Glycosides, Antiplatelet and Antihyperlipidaemics.Conclusions: To conclude, lack of awareness among people about this disease is leading it to progress to advanced stages and prognosis of which is poor. Conducting community awareness programs can play a key component in improving the prognosis of this disease.
No takes yet. Share an insight, caveat, or question.
Mohammad Younus Mohiuddin (2019) conducted an observational in Dilated Cardiomyopathy (n=78). Pharmacotherapy for Dilated Cardiomyopathy was evaluated on Prevalence of Dilated Cardiomyopathy and treatment patterns. Among 78 cardiac outpatients, the prevalence of dilated cardiomyopathy was 17.9%, with the most frequently prescribed treatment being a combination of loop and potassium-sparing diuretics.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: